IFP Advisors’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
IFP Advisors's CRMD Position: Q3 2026 in Review
IFP Advisors increased its CorMedix (CRMD) stake by 2.7% in Q3 2026, buying an estimated $817 and bringing the position to 3,909 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.
IFP Advisors first reported a position in CRMD in Q4 2024 and has held it in 5 quarters since. 189 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.
- IFP Advisors held 3,909 shares of CorMedix worth $30.1K as of Q3 2026.
- IFP Advisors bought 102 CorMedix shares in Q3 2026, an estimated $817.
- CorMedix made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2714 holding.
- IFP Advisors first reported a position in CorMedix in Q4 2024 and has held it in 5 quarters since.
- 189 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.